AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate

Retrieved on: 2021-07-27 13:27:54

Tags for this article:

Click the tags to see associated articles and topics

AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate. View article details on hiswai:

Excerpt

Some of the placement was also picked up by First Capital Partner GmbH. Another lead BioNTech investor, MIG Fonds, is becoming an AC Immune ...

Article found on: www.benzinga.com